Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 7,100,000 | 7,005,000 | 6,666,000 | 6,796,000 | 6,210,000 |
| Cost of Goods | 1,765,000 | 1,763,000 | 1,689,000 | 2,171,000 | 1,500,000 |
| Gross Profit | 5,335,000 | 5,242,000 | 4,977,000 | 4,625,000 | 4,710,000 |
| Operating Expenses | 3,734,000 | 3,541,000 | 3,538,000 | 3,273,000 | 3,241,000 |
| Operating Income | 1,601,000 | 1,701,000 | 1,439,000 | 1,352,000 | 1,469,000 |
| Other Income | 104,000 | 83,000 | 42,000 | -84,000 | 121,000 |
| Pre-tax Income | 1,705,000 | 1,784,000 | 1,481,000 | 1,268,000 | 1,590,000 |
| Income Tax | 266,000 | 343,000 | 248,000 | 187,000 | 271,000 |
| Net Income Continuous | 1,439,000 | 1,441,000 | 1,233,000 | 1,081,000 | 1,319,000 |
| Minority Interests | -1,000 | 17,000 | -4,000 | -6,000 | 42,000 |
| Net Income | $1,440,000 | $1,424,000 | $1,237,000 | $1,087,000 | $1,277,000 |
| EPS Basic Total Ops | 0.61 | 0.60 | 0.52 | 0.51 | 0.52 |
| EPS Basic Continuous Ops | 0.61 | 0.61 | 0.52 | 0.51 | 0.53 |
| EPS Diluted Total Ops | 0.61 | 0.60 | 0.52 | 0.52 | 0.51 |
| EPS Diluted Continuous Ops | 0.61 | 0.61 | 0.52 | 0.49 | 0.53 |
| EBITDA(a) | $2,004,000 | $2,017,000 | $1,748,000 | $1,784,000 | $1,830,000 |